Boraschi D, Pasqualetto E, Ghezzi P, Salmona M, Bartalini M, Barbarulli G, Censini S, Soldateschi D, Tagliabue A
J Immunol. 1983 Oct;131(4):1707-13.
Macrophages (M phi diameter) from three mouse strains with genetically distinct M phi diameter deficits (C3H/HeJ, A/J, and P/J) were unable to develop high cytolytic and cytotoxic activity against tumor cells in vitro when exposed to agents (MAF and IFN-beta) that strongly increased the tumoricidal capacity of M phi diameter from nondefective C3H/HeN mice. Nevertheless, the tumoricidal deficits of M phi diameter from the defective strains did not affect their suppressive capacity on Con A-induced lymphoproliferation, nor their ability to react to IFN-beta by decreasing suppressive activity. In fact, natural suppressive activity and IFN-beta-induced changes in the suppression of M phi diameter from C3H/HeJ, A/J, and P/J mice were highly comparable to those of C3H/HeN M phi diameter, thus stressing the dissociation between the mechanisms governing M phi diameter suppression and M phi diameter tumoricidal activity. Analysis of the modulation by MAF and IFN-beta of M phi diameter ability to release the oxygen metabolites O2- and H2O2, molecules possibly involved in the effector mechanism of both M phi diameter cytotoxicity and suppression, revealed a close correlation with the patterns of suppressive activity in both nondefective and defective strains. In contrast, no correlation between the production of oxygen-reactive species and M phi diameter tumoricidal activity was observed. The ability of MAF- and IFN-beta-treated M phi diameter to produce PGE, a molecule of major importance in M phi diameter-mediated suppression and possibly involved also in the regulation of M phi diameter tumoricidal activity, again paralleled M phi diameter suppressive capacity. Thus, the mechanisms controlling M phi diameter antitumor activity appeared to be clearly distinct from those involved in M phi diameter suppression.
来自三种具有基因上不同巨噬细胞直径缺陷的小鼠品系(C3H/HeJ、A/J和P/J)的巨噬细胞(M phi直径),当暴露于能显著增强无缺陷C3H/HeN小鼠巨噬细胞直径杀瘤能力的因子(巨噬细胞活化因子和β干扰素)时,在体外无法对肿瘤细胞产生高细胞溶解和细胞毒性活性。然而,缺陷品系巨噬细胞直径的杀瘤缺陷并不影响它们对刀豆蛋白A诱导的淋巴细胞增殖的抑制能力,也不影响它们通过降低抑制活性对β干扰素作出反应的能力。事实上,C3H/HeJ、A/J和P/J小鼠巨噬细胞直径的天然抑制活性以及β干扰素诱导的抑制变化与C3H/HeN巨噬细胞直径的高度可比,从而强调了控制巨噬细胞直径抑制机制和巨噬细胞直径杀瘤活性机制之间的分离。对巨噬细胞活化因子和β干扰素对巨噬细胞直径释放氧代谢产物超氧阴离子(O2-)和过氧化氢(H2O2)能力的调节分析,这两种分子可能参与巨噬细胞直径细胞毒性和抑制的效应机制,揭示了与无缺陷和缺陷品系中抑制活性模式密切相关。相反,未观察到氧反应性物质的产生与巨噬细胞直径杀瘤活性之间的相关性。经巨噬细胞活化因子和β干扰素处理的巨噬细胞直径产生前列腺素E(PGE)的能力,前列腺素E是巨噬细胞直径介导的抑制中至关重要的分子,也可能参与巨噬细胞直径杀瘤活性的调节,再次与巨噬细胞直径抑制能力平行。因此,控制巨噬细胞直径抗肿瘤活性的机制似乎与参与巨噬细胞直径抑制的机制明显不同。